Exponent Analyst Price Targets - Benzinga

SPY772.54−0.60%QQQ747.10−1.40%BTC/USD80,429.69−3.42%DIA510.36−0.13%GLD378.90+0.80%TLT77.71+0.73%

Exponent Inc

EXPONASDAQ

Trade with Public

Trade with Public

$68.95

N/A

Last update: Oct 7, 4:01 PM

$68.95

N/A

Overview News Earnings Forecast EventsPrice TargetsFinancials Sentiment Ownership Dividends Compare Options Stock Report

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell

© 2026 Benzinga | All Rights Reserved

Exponent Analyst Price Targets

Wall Street analyst price targets and consensus rating for Exponent (EXPO).

Price Target Range — 7 Quarters

Analyst Consensus — 4 Analysts

3Buy

1Hold

Consensus RatingBuy# Analysts4Avg. Consensus PT$94Upside to Avg. PT+36.3%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Jul 31, 2026	UBS	Joshua Chan	PT Cut	Neutral	$75→$72
Jul 31, 2026	JP Morgan	Tomohiko Sano	PT Raise	Overweight	$80→$90
May 15, 2026	JP Morgan	Tomohiko Sano	PT Cut	Overweight	$95→$80
May 1, 2026	UBS	Joshua Chan	PT Cut	Neutral	$85→$75
Mar 26, 2026	JP Morgan	Tomohiko Sano	PT Cut	Overweight	$100→$95
Jan 26, 2026	JP Morgan	Tomohiko Sano	Initiate	Overweight	$100
Dec 15, 2025	UBS	Joshua Chan	PT Raise	Neutral	$76→$81
Nov 17, 2025	William Blair	Andrew Nicholas	Upgrade	Market Perform→Outperform	—
Jul 26, 2024	Truist Securities	Tobey Sommer	PT Raise	Buy	$100→$120
Apr 29, 2024	Truist Securities	Tobey Sommer	PT Raise	Buy	$95→$100
Feb 2, 2024	Truist Securities	Tobey Sommer	PT Cut	Buy	$110→$95

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
UBS Maintains Neutral on Exponent, Lowers Price Target to $72

UBS analyst Joshua Chan maintains Exponent (NASDAQ:EXPO) with a Neutral and lowers the price target from $75 to $72.

Benzinga Newsdesk

PRO
JP Morgan Maintains Overweight on Exponent, Raises Price Target to $90

JP Morgan analyst Tomohiko Sano maintains Exponent (NASDAQ:EXPO) with a Overweight and raises the price target from $80 to $90.

Benzinga Newsdesk

PRO
JP Morgan Maintains Overweight on Exponent, Lowers Price Target to $80

JP Morgan analyst Tomohiko Sano maintains Exponent (NASDAQ:EXPO) with a Overweight and lowers the price target from $95 to $80.

Benzinga Newsdesk

PRO
UBS Maintains Neutral on Exponent, Lowers Price Target to $75

UBS analyst Joshua Chan maintains Exponent (NASDAQ:EXPO) with a Neutral and lowers the price target from $85 to $75.

Benzinga Newsdesk

PRO
JP Morgan Maintains Overweight on Exponent, Lowers Price Target to $95

JP Morgan analyst Tomohiko Sano maintains Exponent (NASDAQ:EXPO) with a Overweight and lowers the price target from $100 to $95.

Benzinga Newsdesk

PRO
JP Morgan Initiates Coverage On Exponent with Overweight Rating, Announces Price Target of $100

JP Morgan analyst Tomohiko Sano initiates coverage on Exponent (NASDAQ:EXPO) with a Overweight rating and announces Price Target of $100.

Benzinga Newsdesk